-
Manulife US REIT’s 1Q operating data showed stabilising portfolio occupancy and resilient office demand. The proposed Figueroa sale, though at a slight discount, will be a major milestone in Manulife US REIT’s bid to exit its lenders’ Master Restructuring Agreement (MRA).
- - Read this at SGinvestors.io -
Successful Figueroa divestment will clear major MRA hurdle.
-
In March, Manulife US REIT entered into a Sale and Purchase agreement to divest the Figueroa office tower to the Los Angeles municipal entity. The gross sale price of US$92.5m (net: US$85.7m) represents a 6% discount to its end-Dec 2025 valuation. Proceeds from the sale will be used to fully repay its US$36m debt maturing in Jul 2026 and a partial US$37m repayment of its 2027 debt.
- - Read this at SGinvestors.io -
Growth strategy could be delayed to later in 2027.
- Read more at SGinvestors.io.
Above is an excerpt from a report by RHB Securities Research.
Clients of RHB may be the first to access the full PDF report @ https://www.rhbtradesmart.com/.
Vijay Natarajan RHB Securities Research | https://www.rhbgroup.com/ 2026-05-06
Previous report by RHB:
2026-03-19 Manulife US REIT - In Transition.
Price targets by other brokers at Manulife US REIT Target Prices.
Listing of research reports at Manulife US REIT Analyst Reports.
Relevant links:
Manulife US REIT Share Price History,
Manulife US REIT Announcements,
Manulife US REIT Dividend Payout Dates & Corporate Actions,
Manulife US REIT News
